Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies
Active, not recruiting
- Conditions
- Metastatic Prostate Adenocarcinoma
- Interventions
- Drug: Local chemotherapy
- Registration Number
- NCT03611686
- Lead Sponsor
- University Hospital, Rouen
- Brief Summary
Evaluation the overall survival of patients with metastatic prostate adenocarcinoma resistant to castration
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Male
- Target Recruitment
- 219
Inclusion Criteria
- Patient monitored for castration-resistant metastatic prostate
- Patients starting a first or second line treatment as part of castration resistance
- Patient not objecting to the study after reading the information letter
- Patient aged over 18 years
Exclusion Criteria
- Patient monitored for non-metastatic prostate cancer
- Patient monitored for castration-nonresistant prostate cancer
- Patient not able to understand the information letter
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description patient followed for metastatic prostate adenocarcinoma Local chemotherapy patient wil be followed for metastatic prostate adenocarcinoma during 3 years
- Primary Outcome Measures
Name Time Method Number of alive patient 3 years
- Secondary Outcome Measures
Name Time Method Number of alive patient disease free 3 years
Trial Locations
- Locations (1)
Rouen University Hospital
🇫🇷Rouen, France